Whenever possible, ACRIA publishes its results from independent trials conducted at our clinic or in partnership with other research sites across the United States. Some of these results can be viewed below.
TH9507 (tesamorelin) for abdominal fat
ACRIA participated in a multicenter study of 412 patients, who gave themselves subcutaneous injections of either TH9507 or placebo once a day.
NGX-4010 for HIV-related neuropathy
ACRIA was one site in a multicenter study of NGX-4010, a skin patch for pain due to HIV-related neuropathy.
HIV Over 50: ACRIA's Research Study Released
ROAH is a comprehensive research study of 1000 people over the age of 50 living with HIV in New York City.
CAM: Complimentary and Alternative Medicine
A study to determine how PLWHA use CAM to improve their quality of life and how they decide to use different types of CAM treatments.
Cognitive Impairment and HIV
A study to determine the effect of HIV on cognitive function among adults living with HIV/AIDS. This study examined differences in cognitive ability, depression and reading comprehension between HIV-positive and HIV-negative adults.
DAART
A study to examine through directly administered antiretroviral therapy (DAART) the level of adherence required to adequately suppress HIV.
HIV Over 50 Research Initiatives
SAM-e
An open-label trial to determine the antidepressant effects of SAM-e (s-adenosyl-L-methionine, a naturally occurring substance present in the human body) on HIV positive persons with diagnosed Major Depressive Disorder.
Serostim®
A study to examine the efficacy and safety of Recombinant Human Growth Hormorne (Serostim®) to treat the metabolic complications in people living with HIV/AIDS termed lipodystrophy.
SHAMAN SB-300 Diarrhea Study
An open label pilot study to observe the health benefits and safety of orally administered SB-300 in HIV positive persons with chronic diarrhea.
Topical Aspirin
A double blind randomized clinical trial to determine the efficacy of locally applied solutions of aspirin and diethyl ether in the treatment of painful sensory peripheral neuropathy in HIV positive persons.
